Kezar Life Sciences, Inc. (KZR)

Latest Insider Confidence Score

2025Q4

49.9
Bearish

Company insider confidence (by quarter)

2018Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Equal Talent Investments Ltd 10% Owner 6,254,545 Jun 15, 2020
Morningside Venture Investments Ltd 10% Owner 1,947,993 Aug 17, 2023
Cormorant Private Healthcare Fund I, Lp 1,322,909 Jun 20, 2018
Chen Bihua Director 1,007,421 Jun 27, 2018
Cormorant Asset Management, LP 10% Owner 1,007,421 Jun 27, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 2, 2025 Jul 3, 2025 Chiang Pichi Luo SVP, Corporate Controller Sell 47.5 -264 -8.87% $1.1K
Jul 2, 2025 Jul 3, 2025 Schiller Mark C. COO Sell 47.5 -561 -17.00% $2.4K
Jul 1, 2025 Jul 1, 2025 To Zung Phuong Chief Development Officer Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 Klearman Micki Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 Wallace Courtney Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 Garner Elizabeth Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 18, 2025 Jun 23, 2025 Fowler John Franklin Director Neutral 52.5 - 0.00% -
Apr 16, 2025 Chiang Pichi Luo SVP, Corporate Controller Neutral 52.5 - 0.00% -
Apr 16, 2025 To Zung Phoung SVP, Clinical Development Neutral 52.5 - 0.00% -
Mar 27, 2025 Apr 1, 2025 Schiller Mark C. Chief Legal Officer Neutral 52.5 - 0.00% -
Mar 27, 2025 Apr 1, 2025 Belsky Marc CFO Neutral 52.5 - 0.00% -
Mar 4, 2025 Mar 5, 2025 Belsky Marc CFO Neutral 52.5 - 0.00% -
Mar 4, 2025 Mar 5, 2025 Schiller Mark C. Chief Legal Officer Neutral 52.5 - 0.00% -
Feb 14, 2025 Feb 14, 2025 Fowler John Franklin Director Neutral 52.5 - 0.00% -
Jan 9, 2025 Jan 13, 2025 Schiller Mark C. Chief Legal Officer Neutral 52.5 - 0.00% -
Jan 9, 2025 Jan 13, 2025 Belsky Marc CFO Neutral 52.5 - 0.00% -
Jan 9, 2025 Jan 13, 2025 Kirk Christopher J. CEO Neutral 52.5 - 0.00% -
Jul 2, 2024 Jul 26, 2024 Schiller Mark C. Chief Legal Officer Sell 47.5 -6,688 -16.85% $3.9K
Jun 20, 2024 Jun 21, 2024 Wallace Courtney Director Neutral 52.5 - 0.00% -
Jun 20, 2024 Jun 21, 2024 Garner Elizabeth Director Neutral 52.5 - 0.00% -
Jun 20, 2024 Jun 21, 2024 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jun 20, 2024 Jun 21, 2024 Klearman Micki Director Neutral 52.5 - 0.00% -
Jun 20, 2024 Jun 21, 2024 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 20, 2024 Jun 21, 2024 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jan 17, 2024 Schiller Mark C. Chief Legal Officer Neutral 52.5 - 0.00% -
Jan 7, 2024 Jan 9, 2024 Belsky Marc CFO Neutral 52.5 - 0.00% -
Jan 7, 2024 Jan 9, 2024 Mordwinkin Nicholas Michael Chief Business Officer Neutral 52.5 - 0.00% -
Nov 8, 2023 Nov 9, 2023 Kirk Christopher J. CEO Neutral 52.5 - 0.00% -
Aug 15, 2023 Aug 17, 2023 Morningside Venture Investments Ltd 10% Owner Neutral 27.5 -3,500,000 -64.24% -
Jul 24, 2023 Jul 26, 2023 Wallace Courtney Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Mordwinkin Nicholas Michael Chief Business Officer Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Klearman Micki Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Kirk Christopher J. Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Henig Noreen Chief Medical Officer Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Garner Elizabeth Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Fowler John Franklin CEO Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jul 24, 2023 Jul 26, 2023 Belsky Marc CFO Neutral 52.5 - 0.00% -
Jul 20, 2023 Jul 24, 2023 Kirk Christopher J. Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 Garner Elizabeth Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 Wallace Courtney Director Neutral 52.5 - 0.00% -
Jun 15, 2023 Jun 16, 2023 Klearman Micki Director Neutral 52.5 - 0.00% -
Feb 3, 2023 Feb 7, 2023 Morningside Venture Investments Ltd 10% Owner Sell 20.0 -65,000 -1.18% $454K
Feb 1, 2023 Feb 3, 2023 Morningside Venture Investments Ltd 10% Owner Sell 20.0 -90,000 -1.61% $637.5K
Jan 30, 2023 Feb 1, 2023 Morningside Venture Investments Ltd 10% Owner Sell 20.0 -60,000 -1.06% $419.7K
Jan 25, 2023 Jan 27, 2023 Morningside Venture Investments Ltd 10% Owner Sell 30.0 -50,000 -0.88% $342.5K
Jan 23, 2023 Jan 25, 2023 Morningside Venture Investments Ltd 10% Owner Sell 17.5 -160,000 -2.72% $1.1M
Jan 17, 2023 Jan 19, 2023 Morningside Venture Investments Ltd 10% Owner Sell 51.3 -6,114 -0.10% $41.5K
Jan 12, 2023 Jan 17, 2023 Morningside Venture Investments Ltd 10% Owner Sell 51.3 -6,971 -0.12% $47.9K
Oct 18, 2022 Jan 11, 2023 Morningside Venture Investments Ltd 10% Owner Neutral 27.5 -120,000 -1.98% -
Jan 8, 2023 Jan 10, 2023 Mordwinkin Nicholas Michael Chief Business Officer Neutral 52.5 - 0.00% -
Jan 8, 2023 Jan 10, 2023 Kirk Christopher J. President Neutral 52.5 - 0.00% -
Jan 8, 2023 Jan 10, 2023 Belsky Marc CFO Neutral 52.5 - 0.00% -
Jan 8, 2023 Jan 10, 2023 Fowler John Franklin CEO Neutral 52.5 - 0.00% -
Jan 8, 2023 Jan 10, 2023 Henig Noreen Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 5, 2023 Jan 9, 2023 Morningside Venture Investments Ltd 10% Owner Sell 40.0 -15,162 -0.26% $105.4K
Dec 29, 2022 Jan 5, 2023 Morningside Venture Investments Ltd 10% Owner Sell 30.0 -55,500 -0.93% $396.2K
Nov 10, 2022 Nov 14, 2022 Fowler John Franklin CEO Neutral 52.5 - 0.00% -
Oct 3, 2022 Oct 5, 2022 Morningside Venture Investments Ltd 10% Owner Sell 30.0 -32,312 -0.53% $283.8K
Aug 1, 2022 Aug 2, 2022 Mordwinkin Nicholas Michael Chief Business Officer Neutral 52.5 - 0.00% -
Jul 15, 2022 Mordwinkin Nicholas Michael Chief Business Officer Neutral 52.5 - 0.00% -
Jun 23, 2022 Jun 27, 2022 Kirk Christopher J. President Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 Wallace Courtney Director Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 Klearman Micki Director Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 16, 2022 Jun 17, 2022 Garner Elizabeth Director Neutral 52.5 - 0.00% -
May 12, 2022 May 13, 2022 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Mar 18, 2022 Mar 22, 2022 BERGER FRANKLIN M Director Buy 95.0 +80,000 9.87% $1.3M
Jan 5, 2022 Jan 7, 2022 Henig Noreen Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 5, 2022 Jan 7, 2022 Fowler John Franklin CEO Neutral 52.5 - 0.00% -
Jan 5, 2022 Jan 7, 2022 Kirk Christopher J. President Neutral 52.5 - 0.00% -
Jan 5, 2022 Jan 7, 2022 Belsky Marc CFO Neutral 52.5 - 0.00% -
Jan 3, 2022 Jan 5, 2022 Kauffman Michael Director Sell 32.5 -5,000 -7.28% $82.3K
Dec 14, 2021 Dec 15, 2021 Fowler John Franklin CEO Neutral 52.5 - 0.00% -
Dec 9, 2021 Dec 10, 2021 Wallace Courtney Director Neutral 52.5 - 0.00% -
Dec 10, 2021 Wallace Courtney Director Neutral 52.5 - 0.00% -
Sep 21, 2021 Sep 23, 2021 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 Sommadossi Jean-Pierre Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 Klearman Micki Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 Kauffman Michael Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 Garner Elizabeth Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 Dinges Jason Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 COOPER GRAHAM K Director Neutral 52.5 - 0.00% -
Jun 28, 2021 Jun 30, 2021 BERGER FRANKLIN M Director Neutral 52.5 - 0.00% -
Jun 1, 2021 Jun 3, 2021 Klearman Micki Director Neutral 52.5 - 0.00% -
Jun 3, 2021 Klearman Micki Director Neutral 52.5 - 0.00% -
May 30, 2019 Mar 29, 2021 Economides Vassiliki SVP, Strategy & External Aff. Buy 85.0 +750 7.10% $7.6K
Jan 8, 2021 Jan 11, 2021 Kirk Christopher J. President Neutral 52.5 - 0.00% -
Jan 8, 2021 Jan 11, 2021 Henig Noreen Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 8, 2021 Jan 11, 2021 Fowler John Franklin CEO Neutral 52.5 - 0.00% -